|
|
市场分析报告
|
Genital Herpes - Pipeline Insight, 2021 ... Genital Herpes Emerging Drugs Pritelivir: AiCuris Pritelivir is a new small molecule, a helicase ... inhibition of viral DNA polymerase, pritelivir prevents de novo synthesis of viral ... Therapy Designation by U.S. FDA for Pritelivir for the treatment of HSV ...
Global Genital Herpes Research and Development Pipeline Market Growth (Status and Outlook) 2023-2029 ... -003 GV-2207 HerpeCide-I HSV-529 Pritelivir SB-105A10 Segmentation by Application: Hospital Clinic ...
Global Genital Herpes Research and Development Pipeline Market Research Report 2023 ... -003 GV-2207 HerpeCide-I HSV-529 Pritelivir SB-105A10 Segment by Application Hospital Clinic ...
Global Genital Herpes Research and Development Pipeline Market 2022 by Company, Regions, Type and Application, Forecast to 2028 ... -003 GV-2207 HerpeCide-I HSV-529 Pritelivir SB-105A10 Market segment by Application, can ...
Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2020 Herpes Labialis (Oral Herpes) - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis - Pipeline Review, H2 2020, provides an overview of the Herpes Labialis (Infectious Disease ...
Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2020 Herpes Labialis (Oral Herpes) - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis – Pipeline Review, H1 2020, provides an overview of the Herpes Labialis (Infectious Disease ...
Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021 Herpes Labialis (Oral Herpes) (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis - Drugs In Development, 2021, provides an overview of the Herpes ...
Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Herpes Labialis (Oral Herpes) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Herpes Labialis (Oral Herpes) - Drugs In ...
Herpes Simplex - Market Insight, Epidemiology and Market Forecast - 2028 ... . Detailed chapter for upcoming therapies Pritelivir (AiCuris), SQX770 (Squarex), BTL TML ...
Herpes labialis - Pipeline Insight, 2021 ... Key Products BOR15001L7 HDIT-101 Pritelivir BTL-TML Research programme: Herpes ...
Herpes Labialis Drug Development Pipeline Study, H2 2018 Herpes Labialis Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Herpes Labialis pipeline products. DISEASE OVERVIEW Herpes Labialis referred to as cold sores, is a widespread infection ...
Genital Herpes Infection Drug Pipeline Study, H2 2018- Analysis of Phases, Companies, Mechansim, Trials, Current Status of Pipeline Drugs for Genital Herpes Genital Herpes Infection Drug Development Pipeline Study, H2 2018 is the latest infectious disease publication with comprehensive information of Genital Herpes Infection pipeline products. DISEASE OVERVIEW Genital Herpes infection is spread through ...
Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Genital Herpes Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Genital Herpes - Drugs In Development, 2022, provides ...
Herpes Simplex Virus Treatment Market Size, Share & Trends Analysis Report By Treatment (HSV-1, HSV-2), By Drug, By Vaccine, By Route Of Administration, By End-use, By Region, And Segment Forecasts, 2022 - 2030 ... , in July 2021, a Phase III study of pritelivir, a novel drug by AiCuris Anti-infective ...
Global Genital Herpes Research and Development Pipeline Market Research Report 2024(Status and Outlook) ... -003 GV-2207 HerpeCide-I HSV-529 Pritelivir SB-105A10 Market Segmentation (by Application) Hospital ...
|
|
|
|